Dosimetric Impact of Artificial Intelligence (AI)-Based Autocontouring Software, OncoStudio, in High-Risk Prostate

Masumi Kawaguchi1, Masataka Hoshina2, Shinji Sugahara2

  • 1Department of Radiation Oncology, Tokyo Medical University Hospital, Tokyo, JPN.

Cureus
|March 16, 2026
PubMed
Abstract